Roman Butler Fullerton & CO Merck & Co., Inc. Transaction History

Roman Butler Fullerton & CO

$342 Million
Q4 2024

A detailed history of Roman Butler Fullerton & CO transactions in Merck & Co., Inc. stock. As of the latest transaction made, Roman Butler Fullerton & CO holds 10,189 shares of MRK stock, worth $929,950. This represents 0.3% of its overall portfolio holdings.

Number of Shares

10,189

Previous 10,948 6.93%

Holding current value

$929,950

Previous $1.24 Million 18.5%

% of portfolio

0.3%

Previous 0.37%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 30, 2025	SELL	$96.31 - $114.76 $73,099 - $87,102	-759 Reduced 6.93%	10,189 $1.01 Million
Q3 2024 Oct 29, 2024	BUY	$111.15 - $128.97 $32,789 - $38,046	295 Added 2.77%	10,948 $1.24 Million
Q2 2024 Jul 15, 2024	SELL	$123.8 - $132.96 $70,566 - $75,787	-570 Reduced 5.08%	10,653 $1.32 Million
Q1 2024 Apr 29, 2024	SELL	$113.24 - $131.95 $21,289 - $24,806	-188 Reduced 1.65%	11,223 $1.48 Million
Q4 2023 Jan 31, 2024	SELL	$100.18 - $109.02 $6,712 - $7,304	-67 Reduced 0.58%	11,411 $1.24 Million
Q3 2023 Oct 18, 2023	SELL	$102.95 - $114.33 $63,931 - $70,998	-621 Reduced 5.13%	11,478 $1.18 Million
Q2 2023 Jul 25, 2023	SELL	$108.61 - $118.38 $273,371 - $297,962	-2,517 Reduced 17.22%	12,099 $1.4 Million
Q1 2023 Apr 27, 2023	BUY	$102.94 - $114.86 $207,527 - $231,557	2,016 Added 16.0%	14,616 $1.55 Million
Q4 2022 Jan 23, 2023	BUY	$87.44 - $112.11 $93,910 - $120,406	1,074 Added 9.32%	12,600 $0
Q3 2022 Oct 17, 2022	BUY	$84.53 - $94.96 $3,888 - $4,368	46 Added 0.4%	11,526 $1.05 Million
Q2 2022 Jul 26, 2022	BUY	$83.49 - $94.64 $7,430 - $8,422	89 Added 0.78%	11,480 $1.09 Million
Q1 2022 May 05, 2022	BUY	$73.51 - $82.4 $3,601 - $4,037	49 Added 0.43%	11,391 $935,000
Q4 2021 Jan 24, 2022	BUY	$72.28 - $90.54 $21,684 - $27,162	300 Added 2.72%	11,342 $869,000
Q3 2021 Nov 10, 2021	BUY	$71.68 - $78.83 $1,075 - $1,182	15 Added 0.14%	11,042 $852,000
Q2 2021 Jul 29, 2021	SELL	$70.31 - $77.77 $703 - $777	-10 Reduced 0.09%	11,027 $858,000
Q1 2021 Apr 22, 2021	SELL	$68.86 - $81.11 $207,544 - $244,465	-3,014 Reduced 21.45%	11,037 $846,000
Q4 2020 Feb 01, 2021	SELL	$71.77 - $79.65 $78,659 - $87,296	-1,096 Reduced 7.24%	14,051 $1.15 Million
Q3 2020 Oct 15, 2020	SELL	$73.18 - $82.95 $31,906 - $36,166	-436 Reduced 2.8%	15,147 $1.26 Million
Q2 2020 Jul 28, 2020	BUY	$70.42 - $80.13 $1.1 Million - $1.25 Million	15,583 New	15,583 $1.21 Million
Q1 2020 Apr 13, 2020	SELL	$63.36 - $87.82 $1.13 Million - $1.57 Million	-17,888 Closed	0 $0
Q4 2019 Jan 27, 2020	SELL	$77.58 - $87.54 $32,350 - $36,504	-417 Reduced 2.28%	17,888 $1.63 Million
Q3 2019 Oct 15, 2019	SELL	$76.08 - $82.93 $18,639 - $20,317	-245 Reduced 1.32%	18,305 $1.54 Million
Q2 2019 Jul 22, 2019	BUY	$69.84 - $81.59 $8,101 - $9,464	116 Added 0.63%	18,550 $1.56 Million
Q1 2019 Apr 24, 2019	BUY	$69.58 - $79.36 $326,886 - $372,833	4,698 Added 34.2%	18,434 $1.53 Million
Q4 2018 Feb 04, 2019	BUY	$65.24 - $75.71 $896,136 - $1.04 Million	13,736 New	13,736 $1.02 Million

Others Institutions Holding MRK

# of Institutions

3,956

Shares Held

1.94B

Call Options Held

16M

Put Options Held

15M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $231B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Roman Butler Fullerton & CO, based on Form 13F filings with the SEC.

News

Stay updated on Roman Butler Fullerton & CO with notifications on news.

Account

Roman Butler Fullerton & CO Merck & Co., Inc. Transaction History